Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Merck & Co. Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	18,169)	8,007)	8,629)	13,242)	14,593)	11,304)	5,579)	6,841)	8,605)	5,660)	9,707)	12,694)	11,145)	9,675)	8,556)	8,096)	10,016)	8,575)	6,981)	8,062)	7,356)	11,103)	7,425)
Short-term investments	45)	615)	599)	447)	—)	50)	40)	252)	168)	718)	680)	498)	103)	453)	372)	—)	—)	—)	—)	—)	—)	—)	7)
Accounts receivable, net of allowance for doubtful accounts	12,120)	11,846)	10,790)	10,278)	11,381)	11,642)	11,366)	10,349)	10,394)	11,030)	10,415)	9,450)	9,482)	9,643)	9,828)	9,230)	8,571)	7,843)	8,235)	7,851)	8,422)	7,577)	8,182)
Inventories, excludes inventories classified in Other assets	6,444)	6,601)	6,196)	6,109)	6,244)	6,469)	6,510)	6,358)	6,131)	5,930)	5,863)	5,911)	5,614)	5,535)	5,774)	5,953)	5,603)	5,499)	6,402)	6,310)	6,128)	6,056)	5,846)
Other current assets	10,779)	9,996)	9,289)	8,706)	8,143)	8,740)	7,950)	8,368)	6,656)	6,639)	6,737)	7,169)	7,217)	6,810)	6,654)	6,987)	6,868)	6,748)	5,291)	5,541)	4,671)	4,607)	4,714)
Current assets	47,557)	37,065)	35,503)	38,782)	40,361)	38,205)	31,445)	32,168)	31,954)	29,977)	33,402)	35,722)	33,561)	32,116)	31,184)	30,266)	31,058)	28,665)	26,909)	27,764)	26,577)	29,343)	26,174)
Investments	1,117)	774)	616)	463)	575)	357)	280)	252)	1,306)	1,214)	1,290)	1,015)	984)	238)	316)	370)	435)	411)	544)	785)	1,372)	1,251)	555)
Property, plant and equipment, at cost, net of accumulated depreciation	25,639)	25,236)	24,793)	23,779)	23,446)	23,221)	23,045)	23,051)	22,526)	22,231)	21,758)	21,422)	20,424)	20,059)	19,747)	19,279)	18,565)	18,064)	18,295)	17,986)	16,919)	15,789)	15,269)
Goodwill	21,587)	21,591)	21,684)	21,668)	21,697)	21,161)	21,181)	21,197)	21,183)	21,195)	21,209)	21,204)	21,160)	21,213)	21,258)	21,264)	18,862)	18,873)	20,212)	20,238)	20,248)	20,067)	19,767)
Other intangibles, net	15,313)	15,193)	15,758)	16,370)	17,010)	16,984)	17,572)	18,011)	19,199)	19,665)	19,857)	20,269)	21,368)	22,497)	23,022)	22,933)	13,384)	13,622)	14,401)	14,604)	16,677)	16,566)	16,096)
Other assets	18,333)	17,664)	16,768)	16,044)	14,443)	12,702)	12,326)	11,996)	10,559)	10,187)	10,280)	9,528)	9,584)	10,972)	11,141)	11,582)	11,190)	11,053)	10,486)	10,211)	8,007)	7,599)	7,052)
Noncurrent assets	81,989)	80,458)	79,619)	78,324)	77,171)	74,425)	74,404)	74,507)	74,773)	74,492)	74,394)	73,438)	73,520)	74,979)	75,484)	75,428)	62,436)	62,023)	63,938)	63,824)	63,223)	61,272)	58,739)
Total assets	129,546)	117,523)	115,122)	117,106)	117,532)	112,630)	105,849)	106,675)	106,727)	104,469)	107,796)	109,160)	107,081)	107,095)	106,668)	105,694)	93,494)	90,688)	90,847)	91,588)	89,800)	90,615)	84,913)

Cash and cash equivalents: Cash and cash equivalents demonstrated fluctuations over the reported periods, with values peaking notably at the end of 2024 at $14,593 million, before declining slightly and then rising sharply to $18,169 million by the third quarter of 2025. Earlier periods showed variability, with significant amounts maintained but no steady trend.
Short-term investments: Short-term investments were sporadic and relatively minor compared to other asset classes, with some quarters showing no reported amounts. Recent quarters, especially from 2023 onwards, reflected modest increases, peaking at $718 million in mid-2023 before decreasing again.
Accounts receivable, net: Accounts receivable showed a consistent upward trend across the period, starting around $8,182 million and increasing steadily to $12,120 million by late 2025. This indicates growing sales or credit extended to customers, with some minor periodic dips.
Inventories: Inventory levels remained relatively stable with minor fluctuations, ranging mostly between $5,500 million and $6,500 million. A gradual increase is observed toward the later periods, peaking around $6,601 million, suggesting a build-up of stock potentially aligned with sales forecasts or production plans.
Other current assets: Other current assets experienced growth over time, from approximately $4,714 million in early 2020 to $10,779 million by late 2025. This steady increase reflects additional current asset components growing in importance or volume within the company’s asset structure.
Current assets: Total current assets exhibited an overall growth trajectory, increasing from approximately $26,174 million in early 2020 to $47,557 million by the third quarter of 2025. There were temporary declines in mid-2023 but the general direction was upward.
Investments (Noncurrent): Noncurrent investments showed irregular movements with some quarters experiencing decreases and others increases. The values ranged between $238 million and $1,306 million, with a notable dip in 2023 and partial recovery by 2025, indicating fluctuating portfolio adjustments or asset reclassifications.
Property, plant and equipment, net: Property, plant, and equipment displayed steady growth throughout the observed period, rising from $15,269 million in early 2020 to $25,639 million by late 2025. This consistent increase suggests ongoing capital investment and expansion of operational capacity.
Goodwill: Goodwill balances remained relatively stable across the years, hovering around $21,000 million to $22,000 million, with minor variations. This stability reflects consistent acquisition-related intangible assets without major impairments or write-offs.
Other intangibles, net: Other intangible assets revealed a declining trend, decreasing from about $16,096 million to around $15,313 million over the analyzed period. The reduction might be attributed to amortization or impairment of certain intangible assets.
Other assets: Other assets showed a steady increase from $7,052 million to $18,333 million, indicating accumulation of various long-term assets or financial instruments not categorized elsewhere, reflecting growth in diverse asset holdings.
Noncurrent assets: Noncurrent assets demonstrated a general upward movement, growing from $58,739 million to $81,989 million. Despite some minor fluctuations, the increase underscores expansion and investment in long-term resources.
Total assets: Total assets grew from approximately $84,913 million to $129,546 million over the course of the periods, reflecting overall expansion of the company’s asset base. The trend is characterized by consistent asset growth, with some moderate fluctuations but steady accumulation of both current and noncurrent assets.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Merck & Co. Inc. (NYSE:MRK)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data